PARP1 and neoplasm: In terms of the mechanism, PARP inhibitors inhibit DNA repair and aggravate DNA damage, which induces neoantigens and cytosolic DNA, activates the interferon pathway, triggers anti-tumor immunity, and converts immunologically “cold” tumors to “hot” tumors.